HEALTHCARE REALTY TRUST INC (HR)
US42226K1051 - REIT
We assign a fundamental rating of 2 out of 10 to HR. HR was compared to 130 industry peers in the Diversified REITs industry. Both the profitability and financial health of HR have multiple concerns. HR is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year HR has reported negative net income.
In the past year HR had a positive cash flow from operations.
Of the past 5 years HR 4 years were profitable.
HR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
HR has a Return On Assets of -2.23%. This is in the lower half of the industry: HR underperforms 79.69% of its industry peers.
HR's Return On Equity of -4.13% is on the low side compared to the rest of the industry. HR is outperformed by 73.44% of its industry peers.
HR has a Return On Invested Capital of 0.35%. This is amonst the worse of the industry: HR underperforms 89.06% of its industry peers.
HR had an Average Return On Invested Capital over the past 3 years of 1.01%. This is below the industry average of 3.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.23% | ||
| ROE | -4.13% | ||
| ROIC | 0.35% |
ROA(3y)-0.18%
ROA(5y)0.14%
ROE(3y)-0.2%
ROE(5y)0.39%
ROIC(3y)1.01%
ROIC(5y)1.4%
1.3 Margins
The Operating Margin of HR (4.04%) is worse than 89.06% of its industry peers.
HR's Operating Margin has declined in the last couple of years.
The Gross Margin of HR (62.76%) is worse than 67.97% of its industry peers.
In the last couple of years the Gross Margin of HR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.04% | ||
| PM (TTM) | N/A | ||
| GM | 62.76% |
OM growth 3Y-43.5%
OM growth 5Y-29.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-1.68%
2. Health
2.1 Basic Checks
HR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HR has about the same amout of shares outstanding than it did 1 year ago.
HR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HR has a worse debt to assets ratio.
2.2 Solvency
HR has an Altman-Z score of 0.40. This is a bad value and indicates that HR is not financially healthy and even has some risk of bankruptcy.
HR's Altman-Z score of 0.40 is on the low side compared to the rest of the industry. HR is outperformed by 62.50% of its industry peers.
The Debt to FCF ratio of HR is 28.39, which is on the high side as it means it would take HR, 28.39 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 28.39, HR is in the better half of the industry, outperforming 64.06% of the companies in the same industry.
A Debt/Equity ratio of 0.74 indicates that HR is somewhat dependend on debt financing.
The Debt to Equity ratio of HR (0.74) is better than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 28.39 | ||
| Altman-Z | 0.4 |
ROIC/WACC0.05
WACC6.43%
2.3 Liquidity
A Current Ratio of 0.47 indicates that HR may have some problems paying its short term obligations.
The Current ratio of HR (0.47) is worse than 89.06% of its industry peers.
HR has a Quick Ratio of 0.47. This is a bad value and indicates that HR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.47, HR is not doing good in the industry: 85.16% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.47 |
3. Growth
3.1 Past
The earnings per share for HR have decreased strongly by -27.78% in the last year.
The Revenue has grown by 44.09% in the past year. This is a very strong growth!
The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)-27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
Revenue 1Y (TTM)44.09%
Revenue growth 3Y22.06%
Revenue growth 5Y14.05%
Sales Q2Q%-7.84%
3.2 Future
The Earnings Per Share is expected to grow by 12.64% on average over the next years. This is quite good.
The Revenue is expected to decrease by -0.81% on average over the next years.
EPS Next Y-104.61%
EPS Next 2Y20.55%
EPS Next 3Y12.64%
EPS Next 5YN/A
Revenue Next Year-6.04%
Revenue Next 2Y-3.03%
Revenue Next 3Y-0.81%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
HR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
HR's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, HR is valued a bit cheaper than the industry average as 60.94% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.5 | ||
| EV/EBITDA | 13.97 |
4.3 Compensation for Growth
HR's earnings are expected to grow with 12.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.55%
EPS Next 3Y12.64%
5. Dividend
5.1 Amount
HR has a Yearly Dividend Yield of 7.20%, which is a nice return.
HR's Dividend Yield is rather good when compared to the industry average which is at 15.68. HR pays more dividend than 80.47% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.24, HR pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.2% |
5.2 History
The dividend of HR decreases each year by -14.26%.
HR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of HR decreased recently.
Dividend Growth(5Y)-14.26%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
HR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-167.7%
EPS Next 2Y20.55%
EPS Next 3Y12.64%
HEALTHCARE REALTY TRUST INC
NYSE:HR (12/20/2024, 8:17:04 PM)
After market: 17.02 +0.14 (+0.83%)16.88
+0.18 (+1.08%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners107.16%
Inst Owner Change-1.49%
Ins Owners0.92%
Ins Owner Change2.77%
Market Cap5.98B
Analysts74.74
Price Target18.61 (10.25%)
Short Float %4.28%
Short Ratio4.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.2% |
Dividend Growth(5Y)-14.26%
DP-167.7%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.33%
Min EPS beat(2)-34.43%
Max EPS beat(2)5.77%
EPS beat(4)1
Avg EPS beat(4)-49.93%
Min EPS beat(4)-101.53%
Max EPS beat(4)5.77%
EPS beat(8)3
Avg EPS beat(8)104.68%
EPS beat(12)6
Avg EPS beat(12)72.79%
EPS beat(16)9
Avg EPS beat(16)50.09%
Revenue beat(2)0
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-4.55%
Max Revenue beat(2)-0.72%
Revenue beat(4)0
Avg Revenue beat(4)-2.01%
Min Revenue beat(4)-4.55%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)6.47%
Revenue beat(12)1
Avg Revenue beat(12)3.4%
Revenue beat(16)1
Avg Revenue beat(16)2.05%
PT rev (1m)-1.02%
PT rev (3m)0.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5.38%
EPS NY rev (3m)-326.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-9.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.45 | ||
| P/FCF | 33.5 | ||
| P/OCF | 11.97 | ||
| P/B | 0.88 | ||
| P/tB | 0.92 | ||
| EV/EBITDA | 13.97 |
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)0.5
FCFY2.98%
OCF(TTM)1.41
OCFY8.36%
SpS3.79
BVpS19.25
TBVpS18.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.23% | ||
| ROE | -4.13% | ||
| ROCE | 0.44% | ||
| ROIC | 0.35% | ||
| ROICexc | 0.35% | ||
| ROICexgc | 0.36% | ||
| OM | 4.04% | ||
| PM (TTM) | N/A | ||
| GM | 62.76% | ||
| FCFM | 13.29% |
ROA(3y)-0.18%
ROA(5y)0.14%
ROE(3y)-0.2%
ROE(5y)0.39%
ROIC(3y)1.01%
ROIC(5y)1.4%
ROICexc(3y)1.01%
ROICexc(5y)1.42%
ROICexgc(3y)1.03%
ROICexgc(5y)1.43%
ROCE(3y)1.27%
ROCE(5y)1.77%
ROICexcg growth 3Y-44.53%
ROICexcg growth 5Y-30.41%
ROICexc growth 3Y-44.93%
ROICexc growth 5Y-30.59%
OM growth 3Y-43.5%
OM growth 5Y-29.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-1.68%
F-Score5
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 28.39 | ||
| Debt/EBITDA | 6.46 | ||
| Cap/Depr | 43.96% | ||
| Cap/Sales | 23.91% | ||
| Interest Coverage | 0.25 | ||
| Cash Conversion | 63.68% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.47 | ||
| Altman-Z | 0.4 |
F-Score5
WACC6.43%
ROIC/WACC0.05
Cap/Depr(3y)109.07%
Cap/Depr(5y)137.16%
Cap/Sales(3y)48.01%
Cap/Sales(5y)57.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
EPS Next Y-104.61%
EPS Next 2Y20.55%
EPS Next 3Y12.64%
EPS Next 5YN/A
Revenue 1Y (TTM)44.09%
Revenue growth 3Y22.06%
Revenue growth 5Y14.05%
Sales Q2Q%-7.84%
Revenue Next Year-6.04%
Revenue Next 2Y-3.03%
Revenue Next 3Y-0.81%
Revenue Next 5YN/A
EBIT growth 1Y-34.44%
EBIT growth 3Y-31.04%
EBIT growth 5Y-19.55%
EBIT Next Year1213.13%
EBIT Next 3Y138.98%
EBIT Next 5Y93.05%
FCF growth 1Y153.92%
FCF growth 3Y51.95%
FCF growth 5Y-3%
OCF growth 1Y83.29%
OCF growth 3Y8.81%
OCF growth 5Y8.18%